The US skincare disruptor: Post procedure care and Hydrinity's UK launch with Brent Nixon
In this episode of the Aesthetics Business Cast, Vicky Eldridge and Eddie Hooker sit down with Brent Nixon, Chief Operating Officer of Hydrinity Accelerated Skin Science, the fastest growing professional skincare brand in the US.
With over 30 years of experience scaling high growth healthcare, aesthetics and technology businesses, including roles at Laserscope, GE Healthcare, Boston Scientific, CoolSculpting and Restoration Robotics, Brent brings a truly global perspective to the conversation.
Hydrinity's origin story is unlike any other skincare brand. Born out of regenerative medicine and wound care science, the company originally developed advanced wound care products and drug delivery systems for oncology and hematology patients. That heritage now powers a unique dual-weight, injectable-grade hyaluronic acid technology that penetrates deep into the dermis, delivering visible results in as little as two weeks.
In this episode, Brent discusses:
* Why Hydrinity has chosen to launch in the UK and Ireland in partnership with Unique Skin
* The science behind their proprietary low-molecular-weight HA and why it is a category disruptor
* How clinics can rethink post-procedure care to reduce downtime, redness and complications
* The "skinimalism" philosophy and why doing more with less boosts patient compliance
* The launch of Retisone, described as the most significant advancement in retinol science in 10 years
* How practitioners can reframe skincare conversations away from "selling" and toward better patient outcomes
* What UK clinics can learn from the US market, and what makes the UK a critical global player
Whether you are a clinic owner, practitioner or aesthetics business leader, this episode offers valuable insight into the future of skin health, regenerative aesthetics and post-procedure recovery.